Ibis Biosciences (Abbott) has been awarded US Patent No. 8,163,895, "Compositions for use in identification of orthopoxviruses."

Rangarajan Sampath, Thomas Hall, David Ecker, and Steven Hofstadler are named as inventors on the patent.

Provides oligonucleotide primers, and compositions and kits containing the same, for rapid identification of orthopoxviruses by amplification of a segment of viral nucleic acid followed by molecular mass analysis.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Science this week: issues in reproducibility, circulating DNA predicts breast cancer relapse, and more.

Because of an autoimmune disorder, a man has been shedding live polioviruses for 28 years, according to an analysis appearing in PLOS Pathogens.

Being in a long-term collaboration can increase researchers' citation rates by 17 percent, a recent analysis says.

By analyzing tweets, Canadian researchers examine the public's view of gene patenting.